NephroGenex, Inc. Assets, Fair Value Disclosure
NephroGenex, Inc. had Assets, Fair Value Disclosure of $8.19 million as of 2015-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Notes › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:AssetsFairValueDisclosure · last filed 2015-11-12
- 2015-09-30: Assets, Fair Value Disclosure $8.19M.
- 2015-06-30: Assets, Fair Value Disclosure $14.23M.
- 2015-03-31: Assets, Fair Value Disclosure $7.60M.
- 2014-12-31: Assets, Fair Value Disclosure $16.77M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2015-09-30 | $8.19M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $14.23M 10-Q · filed 2015-08-12 |
| 2015-03-31 | $7.60M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $16.77M 10-Q · filed 2015-11-12 |
| 2014-09-30 | $26.62M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $29.86M 10-Q · filed 2014-08-12 |